Skip to content
drillr.ai
Sign up

SGMT

Sagimet Biosciences Inc.

NASDAQ · Healthcare · Biotechnology · US

$11.09
−0.72%
Ask drillr
0
Insider buys (3m)
5
Insider sells (3m)
-$4.5M
Net value (3m)
+55.4%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 17, 2026Kemble George · directorM-Exempt326,618$6.36
Aug 17, 2026Kemble George · directorSale350,987$10
Aug 17, 2026Kemble George · directorM-Exempt24,369$6.36
Aug 12, 2026Kemble George · directorM-Exempt9,751$6.36
Aug 12, 2026Kemble George · directorSale20,206$9.95
Aug 12, 2026Kemble George · directorM-Exempt10,455$6.36
Jul 22, 2026Rozek Elizabeth · officer: Chief Legal & Admin. OfficerSale10,545$7.76
Jul 22, 2026Kemble George · directorSale18,844$7.46
Jul 22, 2026Happel David · director, officer: President & CEOSale64,051$7.76
Jun 15, 2026Phillips Anne M. · directorA-Award39,567$6.48
Jun 15, 2026GRAMMER ELIZABETH A · directorA-Award39,567$6.48
Jun 15, 2026Jarrett Jennifer · directorA-Award39,567$6.48
Jun 15, 2026Hoelscher Paul W. · directorA-Award39,567$6.48
Jun 15, 2026SEIDENBERG BETH C · directorA-Award39,567$6.48
Jun 15, 2026Kemble George · directorA-Award39,567$6.48
Jun 1, 2026Happel David · director, officer: President & CEOA-Award300,000$7.27
Jun 1, 2026Rozek Elizabeth · officer: Chief Legal & Admin. OfficerA-Award100,000$7.27
Jun 1, 2026Grauer Andreas · officer: Chief Medical OfficerA-Award35,000$7.27
Jun 1, 2026Chauche Thierry · officer: Chief Financial OfficerA-Award50,000$7.27
May 14, 2026Grauer Andreas · officer: Chief Medical OfficerA-Award264,759$6.44
Feb 20, 2026Happel David · director, officer: President & CEOA-Award128,000$0.00
Feb 20, 2026Rozek Elizabeth · officer: Chief Legal & Admin. OfficerA-Award44,000$0.00
Feb 20, 2026Chauche Thierry · officer: Chief Financial OfficerA-Award88,000$5.38
Feb 20, 2026Martins Eduardo Bruno · officer: Chief Medical OfficerA-Award88,000$5.38
Feb 20, 2026Martins Eduardo Bruno · officer: Chief Medical OfficerA-Award44,000$0.00
Feb 20, 2026Chauche Thierry · officer: Chief Financial OfficerA-Award44,000$0.00
Feb 20, 2026Happel David · director, officer: President & CEOA-Award256,000$5.38
Feb 20, 2026Rozek Elizabeth · officer: Chief Legal & Admin. OfficerA-Award88,000$5.38
Feb 12, 2026Chauche Thierry · officer: Chief Financial OfficerSale1,312$5.36
Feb 12, 2026Happel David · director, officer: President & CEOSale12,101$5.36
Institutional positioning

13F filings over the trailing two quarters

New 76Increased 68Reduced 32Sold out 23
FilerActionSharesFiled
BlackRock, Inc.Increased6,575,788Aug 7, 2026
BALYASNY ASSET MANAGEMENT L.P.New Position3,626,113Aug 14, 2026
Woodline Partners LPIncreased3,000,652Aug 14, 2026
SILVERARC CAPITAL MANAGEMENT, LLCNew Position2,927,698Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased2,566,272Aug 13, 2026
Caligan Partners LPNew Position2,500,000Aug 14, 2026
BVF INC/ILNew Position2,500,000Aug 14, 2026
Affinity Asset Advisors, LLCIncreased2,497,864Aug 13, 2026
FEDERATED HERMES, INC.Increased2,086,715Aug 12, 2026
GREAT POINT PARTNERS LLCNew Position2,029,933Aug 14, 2026
STATE STREET CORPIncreased1,995,092Aug 7, 2026
Saturn V Capital Management LPNew Position1,479,918Aug 14, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased1,444,019Aug 12, 2026
Blue Owl Capital Holdings LPIncreased1,260,544Aug 11, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position1,098,919May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 17, 2026